Dabur Consumer Health: banking on Ayurveda
Our Corporate Bureau
04 October 2006
New Delhi: Ayurveda is becoming the new buzzword as far as marketing of healthcare products is concerned. Analysts say consumers are showing more interest in Ayurveda because of increasing health consciousness and increasing awareness of the side effects of allopathic medicines.
Dabur India for one, is increasing its focus on its consumer healthcare (CHD) business and plans to introduce a number of new products over the next two years. The company will launch various new products in the classical and branded ethical category of ayurvedic medicinal formulations and will launch four-five new ayurvedic medicines in the near future.
Dabur Consumer Healthcare's medicinal products come in two categories; classical and branded ethical medicines.
In the latter segment, the company plans to launch 14 more products while in the branded ethical segment, which consists of prescribed medicines such as Dabur Mensta, the company will launch four major products. The new launches will be accompanied by new packaging of its products and an aggressive marketing strategy to give an impetus to its CHD business, growing at 38.5 per cent per annum.
The company is also formulating a new strategy for brand — Honitus, which will double the base of the cough and cold brand. The target is to turn Honitus into a Rs15 crore brand in the next two years. Currently, the brand commands a market share of 14 per cent, according to industry estimates.
While Dabur Consumer Healthcare will reach out to the consumers through television and print advertisements, it is also planning a lot of outdoor activities that will include stockists, doctors and the consumer himself.